IL10 and metabolic dysfunction-associated steatotic liver disease: Obesity reduces the level of IL-10 (an anti-inflammatory cytokine), and this, along with overproduction of inflammatory mediators such as tumor necrosis factor-α and IL-6, leads to progression of MASLD [16,17].